1. Home
  2. EVER vs ESPR Comparison

EVER vs ESPR Comparison

Compare EVER & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$23.71

Market Cap

929.5M

Sector

Technology

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.14

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVER
ESPR
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.5M
898.5M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
EVER
ESPR
Price
$23.71
$3.14
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$33.00
$6.67
AVG Volume (30 Days)
389.8K
5.4M
Earning Date
02-23-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
284.14
N/A
EPS
1.44
N/A
Revenue
$644,656,000.00
$303,802,000.00
Revenue This Year
$37.47
$27.49
Revenue Next Year
$14.11
N/A
P/E Ratio
$16.43
N/A
Revenue Growth
57.83
2.83
52 Week Low
$17.35
$0.69
52 Week High
$30.03
$4.18

Technical Indicators

Market Signals
Indicator
EVER
ESPR
Relative Strength Index (RSI) 35.27 39.82
Support Level $23.58 $3.00
Resistance Level $25.12 $3.21
Average True Range (ATR) 0.98 0.22
MACD -0.24 -0.07
Stochastic Oscillator 5.41 21.29

Price Performance

Historical Comparison
EVER
ESPR

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: